BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 10872567)

  • 1. Prevalence of target organ damage in treated hypertensive patients: different impact of clinic and ambulatory blood pressure control.
    Cuspidi C; Lonati L; Sampieri L; Michev I; Macca G; Rocanova JI; Salerno M; Fusi V; Leonetti G; Zanchetti A
    J Hypertens; 2000 Jun; 18(6):803-9. PubMed ID: 10872567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.
    Cuspidi C; Meani S; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A
    J Hum Hypertens; 2005 Jun; 19(6):471-7. PubMed ID: 15744331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control in a hypertension hospital clinic.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Valagussa L; Zaro T; Michev I; Salerno M; Leonetti G; Zanchetti A
    J Hypertens; 1999 Jun; 17(6):835-41. PubMed ID: 10459882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control.
    Cuspidi C; Michev I; Meani S; Salerno M; Valerio C; Fusi V; Bertazzoli G; Magrini F; Zanchetti A
    J Hypertens; 2003 Aug; 21(8):1575-81. PubMed ID: 12872053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension.
    Cuspidi C; Macca G; Sampieri L; Michev I; Salerno M; Fusi V; Severgnini B; Meani S; Magrini F; Zanchetti A
    J Hypertens; 2001 Nov; 19(11):2063-70. PubMed ID: 11677373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy.
    Wiinberg N; Bang LE; Wachtell K; Larsen J; Olsen MH; Tuxen C; Hildebrandt PR; Rokkedal J; Ibsen H; Devereux RB
    J Hum Hypertens; 2004 Jun; 18(6):391-6. PubMed ID: 15057254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
    Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
    Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masked hypertension and target organ damage in treated hypertensive patients.
    Tomiyama M; Horio T; Yoshii M; Takiuchi S; Kamide K; Nakamura S; Yoshihara F; Nakahama H; Inenaga T; Kawano Y
    Am J Hypertens; 2006 Sep; 19(9):880-6. PubMed ID: 16942927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From treatment to organ damage; a 5-year follow-up study of ambulatory blood pressure in essential hypertension. Diversity between development of left ventricular hypertrophy and urinary albumin excretion.
    Stenehjem AE; Bjørnerheim R; Os I
    Blood Press; 2007; 16(2):87-94. PubMed ID: 17612906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of blood pressure control on prevalence of left ventricular hypertrophy in treated hypertensive patients.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Michev I; Salerno M; Fusi V; Leonetti G; Zanchetti A
    Cardiology; 2000; 93(3):149-54. PubMed ID: 10965085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and target organ damage in untreated essential hypertensives.
    Cuspidi C; Meani S; Fusi V; Severgnini B; Valerio C; Catini E; Leonetti G; Magrini F; Zanchetti A
    J Hypertens; 2004 Oct; 22(10):1991-8. PubMed ID: 15361772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients.
    Cuspidi C; Macca G; Sampieri L; Fusi V; Severgnini B; Michev I; Salerno M; Magrini F; Zanchetti A
    J Hypertens; 2001 Sep; 19(9):1539-45. PubMed ID: 11564972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular concentric remodelling and extracardiac target organ damage in essential hypertension.
    Cuspidi C; Macca G; Michev I; Fusi V; Severgnini B; Corti C; Meani S; Valerio C; Sala C; Magrini F; Zanchetti A
    J Hum Hypertens; 2002 Jun; 16(6):385-90. PubMed ID: 12037692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.
    Mancia G; Zanchetti A; Agabiti-Rosei E; Benemio G; De Cesaris R; Fogari R; Pessina A; Porcellati C; Rappelli A; Salvetti A; Trimarco B
    Circulation; 1997 Mar; 95(6):1464-70. PubMed ID: 9118514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure.
    Cuspidi C; Meani S; Salerno M; Valerio C; Fusi V; Severgnini B; Lonati L; Magrini F; Zanchetti A
    J Hypertens; 2004 Feb; 22(2):273-80. PubMed ID: 15076184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circadian rhythm and variability of blood pressure and target organ damage in essential hypertension].
    Cymerys M; Miczke A; Bryl W; Kujawska-Łuczak M; Bogdański P; Pupek-Musialik D
    Pol Arch Med Wewn; 2002 Jul; 108(1):625-31. PubMed ID: 12412406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Night-time home versus ambulatory blood pressure in determining target organ damage.
    Andreadis EA; Agaliotis G; Kollias A; Kolyvas G; Achimastos A; Stergiou GS
    J Hypertens; 2016 Mar; 34(3):438-44; discussion 444. PubMed ID: 26727487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.